CTSO and obesity due to melanocortin 4 receptor deficiency: CTSO gene expression changes have been associated with microsome alterations in obesity in a transcriptome study (43), and increased plasma levels have been associated with the fat mass index (one of the best cardiometabolic disease risk predictors).